An Observational Study, Called VERI-China, to Learn More About How Well Vericiguat Works and How Safe it is in Real-world Setting in People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in China

Name: An Observational Study, Called VERI-China, to Learn More About How Well Vericiguat Works and How Safe it is in Real-world Setting in People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in China
Published: 2023
License: Public Domain

Bayer · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

chronic heart failure with reduced ejection fraction, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

An Observational Study, Called VERI-China, to Learn More About How Well Vericiguat Works and How Safe it is in Real-world Setting in People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in China

Related documents